Leadership Shakeup at Hims & Hers Sends Shares Tumbling

Investors in Hims & Hers Health were taken by surprise as the telehealth company announced a significant restructuring of its executive team after markets closed on Thursday. The departure of Chief Operating Officer Nader Kabbani from his role prompted an immediate and sharp negative reaction in the company’s stock price.

Executive Reshuffle and Market Reaction

Effective November 2, 2025, Nader Kabbani will transition from his COO position to serve as a strategic advisor focusing on global initiatives, a role he will maintain through July 2026. Stepping into the chief operating officer position will be Mike Chi, who previously held the title of Chief Commercial Officer.

The market response was swift and punishing, with shares of Hims & Hers experiencing substantial declines during Friday’s trading session. Unannounced leadership changes at growth-oriented companies frequently raise concerns among investors about management stability and strategic continuity.

Streamlined Management Structure

The promotion of Mike Chi represents part of a broader initiative to simplify the company’s leadership framework. With this reorganization, the Chief Commercial Officer position will be eliminated entirely. Chi will now oversee a consolidated department combining operations, marketing, product development, and sales functions.

Should investors sell immediately? Or is it worth buying Hims & Hers Health Registered (A)?

Chi brings more than twenty years of consumer internet expertise to his new role, with previous leadership experience at companies including Zola and INTERMIX. He has been part of the Hims & Hers team since April 2021.

Regulatory Challenges and Timing Concerns

The timing of this leadership transition presents particular challenges for the company. Hims & Hers continues to navigate a complex regulatory landscape, especially within the profitable weight-loss medication sector. While the company recently benefited from a federal judge dismissing Eli Lilly’s lawsuit against a competitor, regulatory uncertainty remains a significant factor.

All attention now turns to November 2, when the leadership change becomes official. The following day, November 3, is expected to bring the company’s next quarterly earnings report. This will provide newly appointed COO Mike Chi with his first major opportunity to outline his strategic vision for the reorganized company to analysts and shareholders.

The upcoming quarterly results and forward guidance are likely to play a decisive role in determining the stock’s trajectory through the remainder of the year.